Ligand Pharmaceuticals Incorporated (LGND) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $196.17
• Market Cap: $3.77B
• P/E Ratio: 83.94
• EPS: $2.28
• 52-Week High: $212.49
• 52-Week Low: $93.58

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated is a prominent biopharmaceutical company based in San Diego, California, dedicated to advancing drug discovery and development through its innovative technologies tailored for pharmaceutical partners worldwide. The company's extensive portfolio of proprietary solutions enables it to enhance drug efficacy and streamline market access across various therapeutic areas. With a strategic focus on collaboration and a seasoned management team, Ligand is uniquely p...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Ligand Pharmaceuticals Incorporated and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does LGND pay dividends?

Ligand Pharmaceuticals Incorporated (LGND) does not currently pay a regular dividend.

What is LGND's P/E ratio?

Ligand Pharmaceuticals Incorporated has a price-to-earnings (P/E) ratio of 83.94.

What is LGND's market cap?

Ligand Pharmaceuticals Incorporated (LGND) has a market capitalization of $3.77B with a current stock price of $196.17.